Page 1 of Clinical Trials for Biological anti-thymocyte globulin, 133 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Biological Therapy in Treating Patients With Myelodysplastic Syndrome
Last Updated: March 31, 2010
Condition(s): Leukemia; Myelodysplastic Syndromes
2
Active, not recruiting
Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Last Updated: February 6, 2009
Condition(s): Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
3
Completed
Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes
Last Updated: September 13, 2010
Condition(s): Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
4
Completed
Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma
Last Updated: August 29, 2011
Condition(s): Drug/Agent Toxicity by Tissue/Organ; Multiple Myeloma and Plasma Cell Neoplasm
5
Terminated
Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma
Last Updated: August 19, 2011
Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
6
Completed
Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma
Last Updated: November 28, 2011
Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
7
Withdrawn
Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
Last Updated: July 6, 2006
Condition(s): Adult Acute Erythroid Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; Adult Acute Myeloid Leukemia
8
Recruiting
Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants
Last Updated: June 1, 2010
Condition(s): Malignancy; Metabolic Disease; Genetic Disorder
9
Recruiting
High-Dose Cyclophosphamide and Anti-Thymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Systemic Scleroderma
Last Updated: October 7, 2011
Condition(s): Systemic Scleroderma
10
Completed
Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
Last Updated: November 28, 2011
Condition(s): Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
11
Completed
Allogeneic Peripheral Stem Cell Transplant After Antithymocyte Globulin, High-Dose Melphalan, and Fludarabine in Treating Women With Metastatic Adenocarcinoma of the Breast
Last Updated: February 6, 2009
Condition(s): Breast Cancer
12
Recruiting
Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Last Updated: March 23, 2011
Condition(s): Leukemia, Myeloid, Accelerated Phase; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Blast Phase; Contiguous Stage II Adult Burkitt's Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; De Novo Myelodysplastic Syndromes; Mucosa-Associated Lymphoid Tissue Lymphoma; Graft Versus Host Disease; Monocytoid B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt's Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt's Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Adult T-cell Lymphoma/Leukaemia Recurrent; Cutaneous T-cell Lymphoma Recurrent; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Mantle Cell Lymphoma Recurrent; Recurrent Marginal Zone Lymphoma; Mycosis Fungoides/Sezary Syndrome Recurrent; B-cell Small Lymphocytic Lymphoma Recurrent; Chronic Lymphocytic Leukaemia Refractory; Chronic Myelogenous Leukemia in Relapse; Secondary Myelodysplastic Syndromes; Splenic Marginal Zone B-Cell Lymphoma; Stage I Adult Burkitt's Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Adult T-cell Lymphoma/Leukaemia Stage I; Chronic Lymphocytic Leukaemia Stage 1; Cutaneous T-cell Lymphoma Stage I; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Mantle Cell Lymphoma Stage I; Stage I Marginal Zone Lymphoma; Mycosis Fungoides/Sezary Syndrome Stage I; B-cell Small Lymphocytic Lymphoma Stage I; Adult T-cell Lymphoma/Leukaemia Stage II; Chronic Lymphocytic Leukaemia Stage 2; Cutaneous T-cell Lymphoma Stage II; Mycosis Fungoides/Sezary Syndrome Stage II; Stage III Adult Burkitt's Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Adult T-cell Lymphoma/Leukaemia Stage III; Chronic Lymphocytic Leukaemia Stage 3; Cutaneous T-cell Lymphoma Stage III; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Mantle Cell Lymphoma Stage III; Stage III Marginal Zone Lymphoma; Mycosis Fungoides/Sezary Syndrome Stage III; B-cell Small Lymphocytic Lymphoma Stage III; Stage IV Adult Burkitt's Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Adult T-cell Lymphoma/Leukaemia Stage IV; Chronic Lymphocytic Leukaemia Stage 4; Cutaneous T-cell Lymphoma Stage IV; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Mantle Cell Lymphoma Stage IV; Stage IV Marginal Zone Lymphoma; Mycosis Fungoides/Sezary Syndrome Stage IV; B-cell Small Lymphocytic Lymphoma Stage IV; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia; Waldenstrom Macroglobulinemia
13
Recruiting
Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia
Last Updated: June 28, 2011
Condition(s): Aplastic Anemia
14
Recruiting
HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors
Last Updated: January 12, 2012
Condition(s): Acute Leukemia; Myelodysplastic Syndrome; Solid Tumors
15
Terminated
Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant
Last Updated: January 3, 2011
Condition(s): Aplastic Anemia
16
Active, not recruiting
Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors
Last Updated: September 18, 2010
Condition(s): Unspecified Childhood Solid Tumor, Protocol Specific
17
Recruiting
Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
Last Updated: January 10, 2012
Condition(s): Cancer
18
Recruiting
Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Last Updated: February 18, 2011
Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
19
Active, not recruiting
Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
Last Updated: February 6, 2009
Condition(s): Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
20
Recruiting
Sirolimus, Tacrolimus, Antithymocyte Globulin, and Rituximab in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancers or Other Diseases Undergoing Donor Peripheral Blood Stem Cell Transplant
Last Updated: September 26, 2011
Condition(s): Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Biological+anti-thymocyte+globulin

Page 1 of Clinical Trials for Biological anti-thymocyte globulin, 133 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About